Manufacturing, Scaling, and Supply Chain Strategy
Plan manufacturing strategy to ensure quality, cost-effectiveness, and supply reliability at scale.
Manufacturing is often underestimated by biotech founders focused on science. Small-molecule drugs (like aspirin) require chemical synthesis in controlled batches; biologics (antibodies, proteins) require cell culture and purification. Process development—optimizing yields, purity, stability, and cost—happens in parallel with clinical development. Scale-up from lab (grams) to clinical trial (kilograms) to commercial (tons) demands new equipment, regulatory compliance (GMP), and quality systems. Contract manufacturers (CMOs) offer flexibility for startups but add cost and dependency; in-house manufacturing provides control but requires capital. Supply chain vulnerabilities (single-source suppliers, geographic concentration) create risk—as the COVID-19 vaccine rollout revealed. Biotech companies must decide: manufacture internally or…
Sign up free — one personalized lesson every day, matched to your role and goals.
Already have an account? Sign in